spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 18 January 2006
doi: 10.1242/dev.02242

Development 133, 663-673 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow All Versions of this Article:
dev.02242v1
133/4/663    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoch, R. V.
Right arrow Articles by Soriano, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoch, R. V.
Right arrow Articles by Soriano, P.

Context-specific requirements for Fgfr1 signaling through Frs2 and Frs3 during mouse development

Renée V. Hoch and Philippe Soriano*

Program in Developmental Biology, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

* Author for correspondence (e-mail: psoriano{at}fhcrc.org)

Accepted 8 December 2005

Fibroblast growth factor receptor 1 (Fgfr1) plays pleiotropic roles during embryonic development, but the mechanisms by which this receptor signals in vivo have not previously been elucidated. Biochemical studies have implicated Fgf receptor-specific substrates (Frs2, Frs3) as the principal mediators of Fgfr1 signal transduction to the MAPK and PI3K pathways. To determine the developmental requirements for Fgfr1-Frs signaling, we generated mice (Fgfr1{Delta}Frs/{Delta}Frs) in which the Frs2/3-binding site on Fgfr1 is deleted. Fgfr1{Delta}Frs/{Delta}Frs embryos die during late embryogenesis, and exhibit defects in neural tube closure and in the development of the tail bud and pharyngeal arches. However, the mutant receptor is able to drive Fgfr1 functions during gastrulation and somitogenesis, and drives normal MAPK responses to Fgf. These findings indicate that Fgfr1 uses distinct signal transduction mechanisms in different developmental contexts, and that some essential functions of this receptor are mediated by Frs-independent signaling.

Key words: Fgfr1, Frs2, Frs3, Signaling, Gastrulation, Neural tube, Tail bud, Pharyngeal arches




This article has been cited by other articles:


Home page
 Genes Dev.Home page
J. Schmahl, K. Rizzolo, and P. Soriano
The PDGF signaling pathway controls multiple steroid-producing lineages
Genes & Dev., December 1, 2008; 22(23): 3255 - 3267.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
J. Zhang, Y. Lin, Y. Zhang, Y. Lan, C. Lin, A. M. Moon, R. J. Schwartz, J. F. Martin, and F. Wang
Frs2{alpha}-deficiency in cardiac progenitors disrupts a subset of FGF signals required for outflow tract morphogenesis
Development, November 1, 2008; 135(21): 3611 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Zhang, K. McKeehan, Y. Lin, J. Zhang, and F. Wang
Fibroblast Growth Factor Receptor 1 (FGFR1) Tyrosine Phosphorylation Regulates Binding of FGFR Substrate 2{alpha} (FRS2{alpha}) But Not FRS2 to the Receptor
Mol. Endocrinol., January 1, 2008; 22(1): 167 - 175.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
F. M. Vaccarino, D. M. Fagel, Y. Ganat, M. E. Maragnoli, L. R. Ment, Y. Ohkubo, M. L. Schwartz, J. Silbereis, and K. M. Smith
Astroglial Cells in Development, Regeneration, and Repair
Neuroscientist, April 1, 2007; 13(2): 173 - 185.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. P. Eswarakumar, F. Ozcan, E. D. Lew, J. H. Bae, F. Tome, C. J. Booth, D. J. Adams, I. Lax, and J. Schlessinger
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis
PNAS, December 5, 2006; 103(49): 18603 - 18608.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2006